Gland Pharma Ltd slips for fifth straight session

Image
Capital Market
Last Updated : Feb 20 2023 | 9:50 AM IST

Gland Pharma Ltd is quoting at Rs 1304.45, down 0.2% on the day as on 09:19 IST on the NSE. The stock jumped 16.28% in last one year as compared to a 4.36% rally in NIFTY and a 7.67% fall in the Nifty Metal index.

Gland Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 1304.45, down 0.2% on the day as on 09:19 IST on the NSE. The benchmark NIFTY is up around 0.08% on the day, quoting at 17957.7. The Sensex is at 61110.1, up 0.18%.Gland Pharma Ltd has eased around 5.18% in last one month.Meanwhile, Nifty Metal index of which Gland Pharma Ltd is a constituent, has eased around 5.41% in last one month and is currently quoting at 12154.05, down 1.02% on the day. The volume in the stock stood at 7400 shares today, compared to the daily average of 10.04 lakh shares in last one month.

The PE of the stock is 21.96 based on TTM earnings ending December 22.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories

  • Over 30 subscriber-only stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 20 2023 | 9:32 AM IST

Next Story